Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGemma Cann2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
World-Class ‘Accelerator’ To Speed Development Of Crucial Rehabilitation TechnologiesGemma Cann2024-11-28T15:34:26+00:00November 21st, 2024|Investment, News|
Novo Nordisk Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGemma Cann2024-12-05T10:36:15+00:00September 19th, 2024|Accelerator, Investment, News|
NanoSyrinx Closes c. £10 Million Financing And Appoints Dr Edwin Moses As ChairmanGemma Cann2024-11-28T14:22:38+00:00September 11th, 2024|Investment, News|
Kent Science Park & Canterbury Christ Church University Innovation ShowcaseGemma Cann2024-09-09T15:11:58+01:00September 9th, 2024|Kent Science Park, News|
International Recognition For Wilton Centre’s Teenage BeekeeperGemma Cann2024-07-29T11:55:54+01:00July 29th, 2024|Article, News, Wilton Centre|
MediCity Nottingham: 4D Medicine Raises £3.4m For Unique Biomaterial PlatformGemma Cann2024-11-28T14:22:54+00:00July 26th, 2024|Investment, MediCity Nottingham, News|
Pioneer Group Appoints Carter Jonas As Leasing Agent On Manchester’s Hexagon TowerGemma Cann2024-07-11T16:12:14+01:00July 11th, 2024|Hexagon Tower, News|
CHAIN Biotech Closes Seed Round To Accelerate Development Of Its CADD Therapeutic Platform In Immune-OncologyGemma Cann2024-11-28T14:34:43+00:00September 6th, 2023|News|
Pioneer Group And King’s College London To Deliver First-Of-Its-Kind Incubator PartnershipGemma Cann2024-11-28T14:38:39+00:00July 3rd, 2023|Investment, News|
